Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Sep 16;26(2):348–361. doi: 10.1093/neuonc/noad174

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Kaplan-Meier analyses. Patients with recurrent disease are shown in (A), and patients with newly diagnosed DIPG are shown in (B). Patients with recurrent tumors who crossed over to Group 4 salvage therapy are shown in (C). These patients (n = 18) crossed over from Groups 1, 2 and 3a. Curves show the time to start of Group 4, the time to exit from study, and overall survival (all times calculated from study entry). p value is by Log-rank test for the two groups shown. DIPG = diffuse intrinsic pontine glioma; C.I.=confidence interval; OS = overall survival.